Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: Impact on growth in PKU

Molecular Genetics and Metabolism

Volumn 109, Issue 4, 2013, Pages 331-338

  Aldámiz Echevarría, Luis ^a   Bueno, María A ^b   Couce, María L ^c   Lage, Sergio ^a   Dalmau, Jaime ^d   Vitoria, Isidro ^d   Andrade, Fernando ^a   Llarena, Marta ^a   Blasco, Javier ^e   Alcalde, Carlos ^f   Gil, David ^g   García, María C ^h   González Lamuño, Domingo ⁱ   Ruiz, Mónica ^j   Ruiz, María A ^k   González, David ^l   Sánchez Valverde, Felix ^m  

^a HOSPITAL DE CRUCES   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^f HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^h HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

ⁱ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^j HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^k HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^l Maternal and Child Hospital   (Spain)

^m Universidad Pública de Navarra   (Spain)

more..

Author keywords

Growth; Phenylketonuria; Tetrahydrobiopterin

Indexed keywords

(6) LEVO ERYTHRO 5,6,7,8 TETRAHYDROBIOPTERIN; PHENYLALANINE; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG; BIOPTERIN; SAPROPTERIN;

ARTICLE; BODY GROWTH; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PHENYLKETONURIA; PHYSICAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN INTAKE; RETROSPECTIVE STUDY; SCHOOL CHILD; ANALOGS AND DERIVATIVES; BODY COMPOSITION; DIET; DIET THERAPY; DRUG EFFECTS; FOLLOW UP; METABOLISM; PATHOLOGY;

BIOPTERIN; BODY COMPOSITION; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; DIET; FOLLOW-UP STUDIES; HUMANS; PHENYLALANINE; PHENYLKETONURIAS;

EID: 84880782254     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.05.017     Document Type: Article

References (33)

1. Simon E., Schwarz M., Roos J., Dragano N., Geraedts M., Siegrist J., Kamp G., Wendel U. Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual. Life Outcomes 2008, 6:25.
2. Bélanger-Quintana A., Burlina A., Harding C.O., Muntau A.C. Up to date knowledge on different treatment strategies for phenylketonuria. Mol. Genet. Metab. 2011, 104:S19-S25.
3. Nagasaka H., Tsukahara H., Takatani T., Sanayama Y., Takayanagi M., Ohura T., Sakamoto O., Ito T., Wada M., Yoshino M., Ohtake A., Yorifuji T., Hirayama S., Miida T., Fujimoto H., Mochizuki H., Hattori T., Okano Y. Cross-sectional study of bone metabolism with nutrition in adult classical phenylketonuric patients diagnosed by neonatal screening. J. Bone Miner. Metab. 2011, 29:737-743.
4. Demirkol M., Giżewska M., Giovannini M., Walter J. Follow up of phenylketonuria patients. Mol. Genet. Metab. 2011, 104:S31-S39. (Suppl.).
5. Giovannini M., Verduci E., Salvatici E., Paci S., Riva E. Phenylketonuria: nutritional advances and challenges. Nutr. Metab. (Lond.) 2012, 9:7.
6. Kure S., Hou D.C., Ohura T., Iwamoto H., Suzuki S., Sugiyama N., Sakamoto O., Fujii K., Matsubara Y., Narisawa K. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J. Pediatr. 1999, 135:375-378.
7. Cunningham A., Bausell H., Brown M., Chapman M., Defouw K., Ernst S., McClure J., McCune H., O'Steen D., Pender A., Skrabal J., Wessel A., Jurecki E., Shediac R., Prasad S., Gillis J., Cederbaum S. Recommendations for the use of sapropterin in phenylketonuria. Mol. Genet. Metab. 2012, 106:269-276.
8. Couce M.L., Bóveda M.D., Valerio E., Pérez-Muñuzuri A., Fraga J.M. Long-term pharmacological management of phenylketonuria, including patients below the age of 4years. JIMD Reports 2011, 53:91-96.
9. Burton B.K., Bausell H., Katz R., Laduca H., Sullivan C. Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU). Mol. Genet. Metab. 2010, 101:110-114.
10. 4 therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up. J. Inherit. Metab. Dis. 2010, 33:689-695.
11. Carrascosa A., Fernández J.M., Fernández C., Fernández A., López-Siguero J.P., Sánchez E., Sobradillo B., Yeste D. Estudios españoles de crecimiento 2008. Nuevos patrones antropométricos. Endocrinol. Nutr. 2008, 55:484-506.
12. Martínez Pardo M., Bélanger-Quintana A., García Muñoz M.J., Desviat L., Pérez B., Ugarte M. Protocolo de diagnóstico, tratamiento y seguimiento de las hiperfenilalaninemias http://www.ae3com.eu/protocolos/protocolo4.pdf.
13. 4) responsiveness. Metabolism 2012, 61:1809-1816.
14. MacDonald A., Rylance G., Hall S.K., Asplin D., Booth I.W. Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet. Arch. Dis. Child. 1996, 74:412-417.
15. Bickel H., Gerrard J., Hickmans E.M. Influence of phenylalanine intake on phenylketonuria. Lancet 1953, 265:812-813.
16. Hoeks M.P., den Heijer M., Janssen M.C. Adult issues in phenylketonuria. Neth. J. Med. 2009, 67:2-7.
17. Hanley W.B. Adult phenylketonuria. Am. J. Med. 2004, 117:590-595.
18. Mereu T. Adequacy of low-phenylalanine diet. Am. J. Dis. Child. 1967, 113:522-523.
19. Arnold G.L., Vladutiu C.J., Kirby R.S., Blakely E.M., Deluca J.M. Protein insufficiency and linear growth restriction in phenylketonuria. J. Pediatr. 2002, 141:243-246.
20. Hoeksma M., Van Rijn M., Verkerk P.H., Bosch A.M., Mulder M.F., de Klerk J.B., de Koning T.J., Rubio-Gozalbo E., de Vries M., Sauer P.J., van Spronsen F.J. The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria. J. Inherit. Metab. Dis. 2005, 28:845-854.
21. Acosta P.B., Yannicelli S. Protein intake affects phenylalanine requirements and growth of infants with phenylketonuria. Acta Paediatr. Suppl. 1994, 407:66-67.
22. Lässker U., Zschocke J., Blau N., Santer R. Tetrahydrobiopterin responsiveness in phenylketonuria. Two new cases and a review of molecular genetic findings. J. Inherit. Metab. Dis. 2002, 25:65-70.
23. Trefz F.K., Aulela-Scholz C., Blau N. Successful treatment of phenylketonuria with tetrahydrobiopterin. Eur. J. Pediatr. 2001, 160:315.
24. Holm V.A., Knox W.E. Physical growth in phenylketonuria: I. A retrospective study. Pediatrics 1979, 63:694-699.
25. Schaefer F., Burgard P., Batzler U., Rupp A., Schmidt H., Gilli G., Bickel H., Bremer H.J. Growth and skeletal maturation in children with phenylketonuria. Acta Paediatr. 1994, 83:534-541.
26. Dhondt J.L., Largillière C., Moreno L., Farriaux J.P. Physical growth in patients with phenylketonuria. J. Inherit. Metab. Dis. 1995, 18:135-137.
27. van Spronsen F.J., Verkerk P.H., van Houten M., Smit G.P., van der Meer S.B., Bakker H.D., Sengers R.C. Does impaired growth of PKU patients correlate with the strictness of dietary treatment? National Dutch PKU Steering Committee. Acta Paediatr. 1997, 86:816-818.
28. Dobbelaere D., Michaud L., Debrabander A., Vanderbecken S., Gottrand F., Turck D., Farriaux J.P. Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria. J. Inherit. Metab. Dis. 2003, 26:1-11.
29. Karlberg J., Jalil F., Lindblad B.S. Longitudinal analysis of infantile growth in an urban area of Lahore, Pakistan. Acta Paediatr. Scand. 1988, 77:392-401.
30. MacDonald A., Rocha J.C., van Rijn M., Feillet F. Nutrition in phenylketonuria. Mol. Genet. Metab. 2011, 104:S10-S18.
31. Gassió R., Artuch R., Vilaseca M.A., Fusté E., Boix C., Sans A., Campistol J. Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population. Dev. Med. Child Neurol. 2005, 47:443-448.
32. Anastasoaie V., Kurzius L., Forbes P., Waisbren S. Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Mol. Genet. Metab. 2008, 95:17-20.
33. Viau K.S., Wengreen H.J., Ernst S.L., Cantor N.L., Furtado L.V., Longo N. Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria. J. Inherit. Metab. Dis. 2011, 34:963-971.